Clinical Trial for COVID-19.

The purpose of this study is to learn about:

effects of living with COVID-19 and
how effective is nirmatrelvir-ritonavir in treating COVID-19.

This is a study of two groups of COVID-19 patients in Taiwan.

In Group 1 the below participants were included in the study:

Patients of all ages.
Patients who were confirmed to have COVID-19 infection between 01 January 2021 and 31 December 2021.
Cases of patients registered in the databases.

In Group 2 the below participants were included in the study:

Participants who are 12 years or older.
Confirmed to have COVID-19 between 01 January 2022 and 31 December 2022.

Nirmatrelvir-ritonavir is taken by mouth and is used to treat COVID-19.

The study will look at:

the nature of Covid-19 disease.
as well as the experiences of people receiving the nirmatrelvir-ritonavir.

This study will help to:

understand what type of patients will need to be admitted to hospitals.
see severe results due to COVID 19 infection.
have more knowledge on the use of nirmatrelvir/ritonavir on COVID-19.

Closest Location

To find study locations, use the location search box below.

Who may participate

Each clinical study has its own guidelines for who may participate, called eligibility criteria. These factors can include your age, sex, overall health, type and stage of disease, and personal treatment history. However, only the research study staff can determine if you qualify to enroll in the study.

Condition

COVID-19

Sex

Male or Female

Age

0+ years

View more eligibility criteria on ClinicalTrials.gov

A Study to Learn About Effects of Living With COVID-19 and the Use of the Medicines Nirmatrelvir-Ritonavir in Treating COVID-19.

Who may participate

View locations for this study

Nearest Locations found

A Study to Learn About Effects of Living With COVID-19 and the Use of the Medicines Nirmatrelvir-Ritonavir in Treating COVID-19.

Who may participate

View locations for this study

Nearest Locations found

Are you a Healthcare Professional?